Patents by Inventor John Gillespie

John Gillespie has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190031668
    Abstract: Compounds of formula (I) that are capable of acting as purine receptor antagonists, pharmaceutical compositions including the compounds, and methods of making the compounds, are disclosed. The compounds and compositions can be used in treating or preventing disorders related to purine receptor hyperfunctioning.
    Type: Application
    Filed: September 15, 2018
    Publication date: January 31, 2019
    Applicant: Vernalis (R&D) Limited
    Inventors: Samantha Jane Bamford, Roger John Gillespie, Richard Simon Todd
  • Patent number: 10106547
    Abstract: Compounds of formula (I) that are capable of acting as purine receptor antagonists, pharmaceutical compositions including the compounds, and methods of making the compounds, are disclosed. The compounds and compositions can be used in treating or preventing disorders related to purine receptor hyperfunctioning.
    Type: Grant
    Filed: August 21, 2017
    Date of Patent: October 23, 2018
    Assignee: Vernalis (R&D) Limited
    Inventors: Samantha Jane Bamford, Roger John Gillespie, Richard Simon Todd
  • Patent number: 10092690
    Abstract: An infusion pump operable with a syringe having a syringe barrel and a syringe plunger includes a housing having a compartment to receive the syringe and defining a wall, and a syringe clamp moveable towards and away from the wall, the syringe clamp contacting the syringe barrel; a drive mechanism supported and structured and arranged to contact and end of the syringe plunger so as to be able to move the syringe plunger within the syringe barrel; a syringe barrel size sensor including a magnet operably coupled to the syringe clamp, and a sensing member supported by the housing and configured to generate an output indicative of a magnetic field associated with the magnet; and software installed on the pump and programmed to use the output to determine a size of the syringe barrel received by the compartment.
    Type: Grant
    Filed: November 29, 2016
    Date of Patent: October 9, 2018
    Assignee: Baxter International Inc.
    Inventors: John Gillespie, Ralph H. LaBedz, Michael Kenneth Platt, Ronald H. Spang, James Frei Berrill, Matthew Stephen Vogel, Michelle Kowalski Greaney
  • Publication number: 20180242627
    Abstract: The present invention provides food products, nutritional programs, and methods for meeting nutritional needs of subjects with dementia and related cognitive disorders. In one embodiment, the invention provides a food product comprising a reversibly sealed container and a soup, wherein the soup is in the container and comprises a total volume of 200-2000 mls, a vegetable or meat component, 300 to 2500 calories, a macronutrient caloric distribution comprising: 20-80% fat, 10-45% protein, and 10-65% carbohydrate, about 2% to about 40% medium chain triglycerides, omega 3 fatty acids in an amount of 100 to 2000 mg and less than 20 solid food particles having a volume greater than about 20 cm3.
    Type: Application
    Filed: April 29, 2018
    Publication date: August 30, 2018
    Applicant: D&E Gillespie Enterprises LLC
    Inventor: John Gillespie
  • Publication number: 20180228512
    Abstract: Method and system for treating a patient using a compressible, pressure-attenuating device. According to one embodiment, the system is used to treat urinary tract disorders and comprises an access device, a delivery device, a pressure-attenuating device, and a removal device. The access device may be used to create a passageway to an anatomical structure, such as the patient's bladder. The delivery device may be inserted through the passageway created by the access device and may be used to deliver the pressure-attenuating device to the anatomical structure. The removal device may be inserted through the passageway created by the access device and may be used to view the bladder and/or to capture, to deflate and to remove the pressure-attenuating device.
    Type: Application
    Filed: April 10, 2018
    Publication date: August 16, 2018
    Inventors: Kevin G. Connors, Ryan J. Cahill, Peter Dayton, John Gillespie, JR.
  • Publication number: 20180193057
    Abstract: Method and system for treating a patient using a compressible, pressure-attenuating device. According to one embodiment, the system is used to treat urinary tract disorders and comprises an access device, a delivery device, a pressure-attenuating device, and a removal device. The access device may be used to create a passageway to an anatomical structure, such as the patient's bladder. The delivery device may be inserted through the passageway created by the access device and may be used to deliver the pressure-attenuating device to the anatomical structure. The removal device may be inserted through the passageway created by the access device and may be used to view the bladder and/or to capture, to deflate and to remove the pressure-attenuating device.
    Type: Application
    Filed: September 20, 2017
    Publication date: July 12, 2018
    Inventors: Kevin G. Connors, Ryan J. Cahill, Peter Dayton, John Gillespie, JR.
  • Patent number: 9955718
    Abstract: The present invention provides food products, nutritional programs, and methods for meeting nutritional needs of subjects with dementia and related cognitive disorders. In one embodiment, the invention provides a food product comprising a reversibly sealed container and a soup, wherein the soup is in the container and comprises a total volume of 200-2000 mls, a vegetable or meat component, 300 to 2500 calories, a macronutrient caloric distribution comprising: 20-80% fat, 10-45% protein, and 10-65% carbohydrate, about 2% to about 40% medium chain triglycerides, omega 3 fatty acids in an amount of 100 to 2000 mg and less than 20 solid food particles having a volume greater than about 20 cm3.
    Type: Grant
    Filed: April 27, 2016
    Date of Patent: May 1, 2018
    Assignee: D&E Gillespie Enterprises LLC
    Inventor: John Gillespie
  • Patent number: 9937289
    Abstract: A method of delivering a medical fluid to a patient includes enabling the attachment of an infusion pump housing to an external support, enabling the viewing of information right-side-up on a display screen of the infusion pump housing, enabling the rotation of the display screen approximately 90 degrees about an axis extending perpendicularly from the display screen, automatically reorienting the information on the display screen so that the information remains right-side-up after rotation, enabling the viewing of the information right-side-up on the display screen after rotation, and enabling the delivery of a flowable material to the patient through an infusion line attached to the infusion pump housing before and after rotation.
    Type: Grant
    Filed: November 12, 2014
    Date of Patent: April 10, 2018
    Assignee: BAXTER INTERNATIONAL INC.
    Inventors: John Gillespie, Jr., Ralph H. LaBedz, Michael Kenneth Platt, Ronald H. Spang, Jr., James Frei Berrill, Matthew Stephen Vogel, Michelle Kowalski Greaney
  • Publication number: 20180045730
    Abstract: A method for identifying cancer patients that are likely to be responders or non-responders to a signal transduction pathway inhibitor is described.
    Type: Application
    Filed: July 21, 2017
    Publication date: February 15, 2018
    Applicant: 20/20 GeneSystems, Inc.
    Inventors: Jonathan Cohen, Alexandrine Josephe Derrien-Colemyn, John Gillespie, Soon Sik Park
  • Publication number: 20170342081
    Abstract: Compounds of formula (I) that are capable of acting as purine receptor antagonists, pharmaceutical compositions including the compounds, and methods of making the compounds, are disclosed. The compounds and compositions can be used in treating or preventing disorders related to purine receptor hyperfunctioning.
    Type: Application
    Filed: August 21, 2017
    Publication date: November 30, 2017
    Applicant: Vernalis (R&D) Limited
    Inventors: Samantha Jane Bamford, Roger John Gillespie, Richard Simon Todd
  • Patent number: 9765080
    Abstract: Compounds of formula (I) that are capable of acting as purine receptor antagonists, pharmaceutical compositions including the compounds, and methods of making the compounds, are. disclosed. The compounds and compositions can be used in treating or preventing disorders related to purine receptor hyperfunctioning.
    Type: Grant
    Filed: June 2, 2016
    Date of Patent: September 19, 2017
    Assignee: Vernalis (R&D) Limited
    Inventors: Samantha Jane Bamford, Roger John Gillespie, Richard Simon Todd
  • Patent number: 9727098
    Abstract: A redundant power supply motherboard assembly connects control segments of a fieldbus-type control system to a host computer. The assembly has a compact design with pairs of power supply modules in side-by-side nests on the motherboard. The nests are mounted on the motherboard in desired locations and securely hold the modules on the assembly despite vibrations, shocks and handling to prevent contact impairment. The nests provide touch protection for components on the motherboard.
    Type: Grant
    Filed: April 1, 2015
    Date of Patent: August 8, 2017
    Assignee: Phoenix Contact Development and Manufacturing, Inc.
    Inventors: Brian John Gillespie, Terry Lee Barber, Michael Anthony Correll
  • Publication number: 20170127929
    Abstract: An implant delivery system can be configured to deliver an inflatable implant into a bladder via a urethra. The delivery system can comprise an elongate tubular body, an inflation tube and an implant decoupler. The tubular body can comprise a central lumen configured to hold an inflatable implant in an initial un-inflated state for delivery of the implant into the bladder. A method of use can include passing a distal tip of the elongate tubular body into the bladder. The implant can be inflated and released into the bladder.
    Type: Application
    Filed: October 14, 2016
    Publication date: May 11, 2017
    Inventors: Ernest G. Schutt, Kevin G. Connors, John Gillespie, Peter Dayton
  • Publication number: 20170088552
    Abstract: Compounds of formula (I) that are capable of acting as purine receptor antagonists, pharmaceutical compositions including the compounds, and methods of making the compounds, are. disclosed. The compounds and compositions can be used in treating or preventing disorders related to purine receptor hyperfunctioning.
    Type: Application
    Filed: June 2, 2016
    Publication date: March 30, 2017
    Applicant: Vernalis (R&D) Limited
    Inventors: Samantha Jane Bamford, Roger John Gillespie, Richard Simon Todd
  • Publication number: 20170072133
    Abstract: An infusion pump operable with a syringe having a syringe barrel and a syringe plunger includes a housing having a compartment to receive the syringe and defining a wall, and a syringe clamp moveable towards and away from the wall, the syringe clamp contacting the syringe barrel; a drive mechanism supported and structured and arranged to contact and end of the syringe plunger so as to be able to move the syringe plunger within the syringe barrel; a syringe barrel size sensor including a magnet operably coupled to the syringe clamp, and a sensing member supported by the housing and configured to generate an output indicative of a magnetic field associated with the magnet; and software installed on the pump and programmed to use the output to determine a size of the syringe barrel received by the compartment.
    Type: Application
    Filed: November 29, 2016
    Publication date: March 16, 2017
    Inventors: John Gillespie, Ralph H. LaBedz, Michael Kenneth Platt, Ronald H. Spang, James Frei Berrill, Matthew Stephen Vogel, Michelle Kowalski Greaney
  • Patent number: 9514518
    Abstract: An infusion pump includes a housing having a compartment structured to receive a syringe and a drive mechanism supported by the housing. The drive mechanism is structured and arranged to contact a syringe plunger of the syringe and move the syringe plunger within a syringe barrel of the syringe. The infusion pump further includes a syringe plunger position sensor and a syringe barrel size sensor. The sensors each include a magnet positioned on the drive mechanism and a magnetic sensor array supported by the housing.
    Type: Grant
    Filed: March 17, 2014
    Date of Patent: December 6, 2016
    Assignee: Baxter International Inc.
    Inventors: John Gillespie, Ralph H. LaBedz, Michael Kenneth Platt, Ronald H. Spang, James Frei Berrill, Matthew Stephen Vogel, Michelle Kowalski Greaney
  • Patent number: 9498195
    Abstract: An implant for use in a human or animal body can include a flexible housing with an outer wall and having a chamber therein. The implant can have at least one high vapor pressure medium within the chamber. The at least one high vapor pressure medium can have a combined vapor pressure equal to or greater than about the average value of the hydrostatic pressure of the implantation site plus the skin tension of the housing minus the gas tension of the dissolved gasses present at the implantation site.
    Type: Grant
    Filed: November 25, 2013
    Date of Patent: November 22, 2016
    Assignee: AttenueX Technologies, Inc.
    Inventors: Ernest G. Schutt, Kevin G. Connors, John Gillespie, Jr., Peter Dayton
  • Patent number: 9456628
    Abstract: The present invention provides food products, nutritional programs, and methods for meeting nutritional needs of subjects with dementia and related cognitive disorders. In one embodiment, the invention provides a food product comprising a reversibly sealed container and a soup, wherein the soup is in the container and comprises a total volume of 200-2000 mls, a vegetable or meat component, 300 to 2500 calories, a macronutrient caloric distribution comprising: 20-80% fat, 10-45% protein, and 10-65% carbohydrate, about 2% to about 40% medium chain triglycerides, omega 3 fatty acids in an amount of 100 to 2000 mg and less than 20 solid food particles having a volume greater than about 20 cm3.
    Type: Grant
    Filed: June 13, 2014
    Date of Patent: October 4, 2016
    Assignee: D&E Gillespie Enterpries LLC
    Inventor: John Gillespie
  • Patent number: 9436233
    Abstract: A redundant power supply motherboard assembly connects control segments of a fieldbus-type control system to a host computer. The assembly has a compact design with pairs of power supply modules mounted in nests on the motherboard. The nests securely hold the modules to prevent contact impairment due to vibrations, shocks and handling.
    Type: Grant
    Filed: April 24, 2015
    Date of Patent: September 6, 2016
    Assignee: Phoenix Contact Development and Manufacturing, Inc.
    Inventors: Michael Anthony Correll, Brian John Gillespie, Terry Lee Barber
  • Publication number: 20160242451
    Abstract: The present invention provides food products, nutritional programs, and methods for meeting nutritional needs of subjects with dementia and related cognitive disorders. In one embodiment, the invention provides a food product comprising a reversibly sealed container and a soup, wherein the soup is in the container and comprises a total volume of 200-2000 mls, a vegetable or meat component, 300 to 2500 calories, a macronutrient caloric distribution comprising: 20-80% fat, 10-45% protein, and 10-65% carbohydrate, about 2% to about 40% medium chain triglycerides, omega 3 fatty acids in an amount of 100 to 2000 mg and less than 20 solid food particles having a volume greater than about 20 cm3.
    Type: Application
    Filed: April 27, 2016
    Publication date: August 25, 2016
    Applicant: D&E Gillespie Enterprises LLC
    Inventor: John Gillespie